Form 4 holding
President, CEO, & Director, Director
AtriCure, Inc.
- Security class
- Common Stock
- Shares / value
- 774,434
- Estimated value
- $21,668,663
- Report date
- 30 Jul 2026
- Price
- $27.98
- Ownership
- Direct
Michael H. Carrel
Insider Reports History
- Reporting-owner location
- Mason, OH
- Latest reporting-owner signature
-
/s/ Michael H. Carrel
Source: Latest parsed Forms 3/4/5 signature
- Transaction source note
- Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
Names, identifiers, and filing context for this profile.
1 identity field
SEC source record
Original filing metadata and source links for verification.
1 source field
Source evidence
Original filing metadata and source links for verification.
1 source field
Reported holdings for Michael H. Carrel
Form 4 holding
President, CEO, & Director, Director
AtriCure, Inc.
- Security class
- Common Stock
- Shares / value
- 14,310
- Estimated value
- $400,393
- Report date
- 30 Jul 2026
- Price
- $27.98
- Ownership
- Held by reporting person's children
Form 4 holding
Director
Inspire Medical Systems, Inc.
- Security class
- Common Stock
- Shares / value
- 5,631
- Estimated value
- $251,198
- Report date
- 20 Jul 2026
- Price
- $44.61
- Ownership
- Direct
Form 4 holding
President, CEO, & Director, Director
AtriCure, Inc.
- Security class
- Common Stock
- Shares / value
- 2,950
- Estimated value
- $82,541
- Report date
- 30 Jul 2026
- Price
- $27.98
- Ownership
- Held by reporting person's parent
Form 4 holding
President, CEO, & Director, Director
AtriCure, Inc.
- Security class
- Common Stock
- Shares / value
- 2,250
- Estimated value
- $64,192
- Report date
- 30 Jun 2026
- Price
- $28.53
- Ownership
- Held by reporting person's parents
Form 4 holding
President, CEO, & Director, Director
AtriCure, Inc.
- Security class
- Common Stock
- Shares / value
- 1,000
- Estimated value
- $27,980
- Report date
- 30 Jul 2026
- Price
- $27.98
- Ownership
- Held by reporting person's sibling
Form 4 holding
Director
Axonics, Inc.
- Security class
- Common Stock
- Shares / value
- 0
- Estimated value
- $0
- Report date
- 15 Nov 2024
- Price
- $71.00
- Ownership
- Direct
Form 4 holding
Director
Axonics, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 0
- Estimated value
- $0
- Report date
- 15 Nov 2024
- Price
- $50.15
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Insider Reports Filed by Michael H. Carrel
4
ATRC
AtriCure, Inc.
- Report period
- 30 Jul 2026
- Transactions
- 2
- Transaction value
- $0
- Accepted by SEC
- 03 Aug 2026, 07:18
- Role
- President, CEO, & Director, Director
- Next action
- Open filing details
4
INSP
Inspire Medical Systems, Inc.
- Report period
- 20 Jul 2026
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 27 Jul 2026, 19:10
- Role
- Director
- Next action
- Open filing details
3
INSP
Inspire Medical Systems, Inc.
- Report period
- 20 Jul 2026
- Transactions
- 0
- Transaction value
- $0
- Accepted by SEC
- 27 Jul 2026, 19:08
- Role
- Director
- Next action
- Open filing details
4
ATRC
AtriCure, Inc.
- Report period
- 30 Jun 2026
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 02 Jul 2026, 09:06
- Role
- President, CEO, & Director, Director
- Next action
- Open filing details
4
ATRC
AtriCure, Inc.
- Report period
- 06 Mar 2026
- Transactions
- 2
- Transaction value
- $0
- Accepted by SEC
- 09 Mar 2026, 08:32
- Role
- President, CEO, & Director, Director
- Next action
- Open filing details
4
ATRC
AtriCure, Inc.
- Report period
- 01 Mar 2026
- Transactions
- 3
- Transaction value
- -$2,275,009
- Accepted by SEC
- 03 Mar 2026, 16:53
- Role
- President, CEO, & Director, Director
- Next action
- Open filing details
4
ATRC
AtriCure, Inc.
- Report period
- 10 Dec 2025
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 12 Dec 2025, 08:26
- Role
- President, CEO, & Director, Director
- Next action
- Open filing details
4
ATRC
AtriCure, Inc.
- Report period
- 13 Nov 2025
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 17 Nov 2025, 17:11
- Role
- President, CEO, & Director, Director
- Next action
- Open filing details
4
ATRC
AtriCure, Inc.
- Report period
- 08 Aug 2025
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 12 Aug 2025, 08:21
- Role
- President, CEO, & Director, Director
- Next action
- Open filing details
4
ATRC
AtriCure, Inc.
- Report period
- 30 Jun 2025
- Transactions
- 1
- Transaction value
- +$21,240
- Accepted by SEC
- 02 Jul 2025, 08:48
- Role
- President, CEO, & Director, Director
- Next action
- Open filing details
4
ATRC
AtriCure, Inc.
- Report period
- 10 Mar 2025
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 12 Mar 2025, 16:22
- Role
- President, CEO, & Director, Director
- Next action
- Open filing details
4
ATRC
AtriCure, Inc.
- Report period
- 01 Mar 2025
- Transactions
- 3
- Transaction value
- -$1,701,693
- Accepted by SEC
- 04 Mar 2025, 17:00
- Role
- President, CEO, & Director, Director
- Next action
- Open filing details
4
Axonics, Inc.
- Report period
- 15 Nov 2024
- Transactions
- 3
- Transaction value
- -$1,954,131
- Accepted by SEC
- 15 Nov 2024, 08:58
- Role
- Director
- Next action
- Open filing details
4
ATRC
AtriCure, Inc.
- Report period
- 14 Aug 2024
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 16 Aug 2024, 08:46
- Role
- President, CEO, & Director, Director
- Next action
- Open filing details
4
ATRC
AtriCure, Inc.
- Report period
- 28 Jun 2024
- Transactions
- 1
- Transaction value
- +$13,680
- Accepted by SEC
- 02 Jul 2024, 16:25
- Role
- President, CEO, & Director, Director
- Next action
- Open filing details
4
ATRC
AtriCure, Inc.
- Report period
- 14 Mar 2024
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 18 Mar 2024, 08:47
- Role
- President, CEO, & Director, Director
- Next action
- Open filing details
4
ATRC
AtriCure, Inc.
- Report period
- 01 Mar 2024
- Transactions
- 3
- Transaction value
- -$1,735,055
- Accepted by SEC
- 05 Mar 2024, 16:46
- Role
- President, CEO, & Director, Director
- Next action
- Open filing details
4
ATRC
AtriCure, Inc.
- Report period
- 27 Nov 2023
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 29 Nov 2023, 09:00
- Role
- President, CEO, & Director, Director
- Next action
- Open filing details
4
Axonics, Inc.
- Report period
- 08 Aug 2023
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 08 Aug 2023, 20:42
- Role
- Director
- Next action
- Open filing details
4
ATRC
AtriCure, Inc.
- Report period
- 04 Aug 2023
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 08 Aug 2023, 09:19
- Role
- President, CEO, & Director, Director
- Next action
- Open filing details
4
ATRC
AtriCure, Inc.
- Report period
- 30 Jun 2023
- Transactions
- 1
- Transaction value
- +$21,227
- Accepted by SEC
- 03 Jul 2023, 08:12
- Role
- President, CEO, & Director, Director
- Next action
- Open filing details
4
Axonics, Inc.
- Report period
- 26 Jun 2023
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 28 Jun 2023, 20:21
- Role
- Director
- Next action
- Open filing details
4
ATRC
AtriCure, Inc.
- Report period
- 31 May 2023
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 01 Jun 2023, 09:12
- Role
- President, CEO, & Director, Director
- Next action
- Open filing details
4
ATRC
AtriCure, Inc.
- Report period
- 01 Mar 2023
- Transactions
- 5
- Transaction value
- -$1,764,691
- Accepted by SEC
- 03 Mar 2023, 16:16
- Role
- President, CEO, & Director, Director
- Next action
- Open filing details
4
ATRC
AtriCure, Inc.
- Report period
- 17 Nov 2022
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 21 Nov 2022, 15:02
- Role
- President, CEO, & Director, Director
- Next action
- Open filing details
4
Axonics, Inc.
- Report period
- 18 Aug 2022
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 22 Aug 2022, 20:13
- Role
- Director
- Next action
- Open filing details
4
ATRC
AtriCure, Inc.
- Report period
- 30 Jun 2022
- Transactions
- 1
- Transaction value
- +$12,156
- Accepted by SEC
- 05 Jul 2022, 16:22
- Role
- President, CEO, & Director, Director
- Next action
- Open filing details
4
ATRC
AtriCure, Inc.
- Report period
- 01 Mar 2022
- Transactions
- 3
- Transaction value
- -$3,003,992
- Accepted by SEC
- 03 Mar 2022, 15:31
- Role
- President, CEO, & Director, Director
- Next action
- Open filing details
4
ATRC
AtriCure, Inc.
- Report period
- 24 Feb 2022
- Transactions
- 2
- Transaction value
- $0
- Accepted by SEC
- 28 Feb 2022, 07:58
- Role
- President, CEO, & Director, Director
- Next action
- Open filing details
4
ATRC
AtriCure, Inc.
- Report period
- 31 Dec 2021
- Transactions
- 1
- Transaction value
- +$8,333
- Accepted by SEC
- 04 Jan 2022, 07:31
- Role
- President, CEO, & Director, Director
- Next action
- Open filing details
4
ATRC
AtriCure, Inc.
- Report period
- 07 Dec 2021
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 09 Dec 2021, 15:19
- Role
- President, CEO, & Director, Director
- Next action
- Open filing details
4
ATRC
AtriCure, Inc.
- Report period
- 10 Nov 2021
- Transactions
- 2
- Transaction value
- $0
- Accepted by SEC
- 12 Nov 2021, 15:38
- Role
- President, CEO, & Director, Director
- Next action
- Open filing details
4
Axonics, Inc.
- Report period
- 22 Oct 2021
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 02 Nov 2021, 21:15
- Role
- Director
- Next action
- Open filing details
4
ATRC
AtriCure, Inc.
- Report period
- 30 Jun 2021
- Transactions
- 1
- Transaction value
- +$11,476
- Accepted by SEC
- 02 Jul 2021, 16:16
- Role
- President, CEO, & Director, Director
- Next action
- Open filing details